Cramer Defends CrowdStrike After Extraordinary ARR Beat
CrowdStrike posted a strong ARR beat and raised guidance, sparking a spirited defense from Jim Cramer as shares softe...
Which Guide To Retirement Planning
Choosing the right guide to retirement planning is crucial for your future. Learn essential steps to secure a comfortable retirement.
22,974 articlesChipotle Starbucks Turnaround Real? A Tale of Two Paths
Starbucks shows a credible turnaround with rising traffic and profits, while Chipotle contends with growth fatigue an...
XRP Price Analysis: Will Inflows Stall as Price Near $1?
XRP is testing the $1 threshold as ETF inflows stall after a weeks-long surge. This price analysis evaluates implicat...
Marvell Technology Rallied: Why the Stock Jumped in May
In May, Marvell Technology delivered more than a beat on sentiment, aided by AI infrastructure demand and a strategic...
Nasdaq Rebounding Monday: Oil Rally Tests AI Bets Now
Tech stocks staged a partial recovery on Monday as the Nasdaq rebounded, but higher oil prices and stubborn yields ke...
Missed Rally? Reasons Watch MercadoLibre After Pullback
Missed the AI rally? Reasons watch MercadoLibre now. This guide breaks down three actionable catalysts, real-world sc...
Will This Jensen Huang-Endorsed AI Chip Stock Really Soar?
A high-profile nod from a tech legend can spark instant moves in AI chip stocks. This guide explains how to separate ...
Bitcoin Jumps Above $62,000 as CPI Relief Lifts Market
Bitcoin moved back above the $62,000 mark after a CPI release eased rate-hike fears, signaling a tentative relief ral...
U.S. Inflation Hits 3-Year-High, Pressure on Households
May inflation data show the U.S. economy warming faster than expected, pushing the annual pace of price growth to a t...
Gamestop Surges Beat on Buyback, New Target Signal
GameStop posts a strong Q1 FY26 beat and authorizes a $2 billion buyback, signaling a pivot to a cash-rich model. The...
How Companies Sneak Chemicals Past FDA Rules Into Foods
Regulators warn of a loophole that allows new chemicals to enter foods and supplements without premarket approval. Th...
AbbVie Reports Promising Clinical Updates, Dividend Outlook
AbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status